The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

New England Journal of Medicine

Volumn 332, Issue 8, 1995, Pages 488-493

  Anderson, Todd J ^a   Meredith, Ian T ^a   Yeung, Alan C ^a   Frei, Balz ^b   Selwyn, Andrew P ^a   Ganz, Peter ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIOXIDANT; CHOLESTEROL; COLESTYRAMINE; HYPOCHOLESTEROLEMIC AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PROBUCOL;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CONSTRICTION; CORONARY ARTERY DILATATION; DIET THERAPY; DOSE RESPONSE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCHOLINE; ANTICHOLESTEREMIC AGENTS; ANTIOXIDANTS; CHOLESTYRAMINE; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; MIDDLE AGED; PROBUCOL; REGRESSION ANALYSIS; VASOCONSTRICTION; VASODILATION;

EID: 0028939363     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199502233320802     Document Type: Article

References (28)

1. Kannel WB, Castelli WP, Gordon T, McNamara PM Serum cholesterol, lipoproteins, and the risk of coronary heart disease: the Framingham Study. Ann Intern Med 1971; 74: 1-12
2. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA 1982; 248: 1465-1477.
3. Lipid Research Clinics Program The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984; 251: 351-364
4. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-1389.
5. Brown G, Albers JJ, Fisher LD, Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990; 323: 1289-1298.
6. Brown BG, Zhao X-Q, Sacco DE, Albers JJ Lipid lowering and plaque regression: new insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993; 87: 1781-1791.
7. Moncada S, Higgs A The l-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
8. Furchgott RF, Zawadzki JV The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376
9. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 344: 160-162
10. Ludmer PL, Selwyn AP, Shook TL, Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-1051.
11. Vita JA, Treasure CB, Nabel EG, Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 1990; 81: 491-497
12. Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88: 2139-2148.
13. Meredith IT, Yeung AC, Weidinger FF, Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease. Circulation 1993; 87: Suppl: V-56
14. Gage JE, Hess OM, Murakami T, Ritter M, Grimm J, Krayenbuehl HP Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin. Circulation 1986; 73: 865-876
15. Yeung AC, Vekshtein VI, Krantz DS, The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med 1991; 325: 1551-1556.
16. Harrison DG, Armstrong ML, Freiman PC, Heistad DD Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987; 80: 1808-1811.
17. Osborne JA, Lento PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM Cardiovascular effects of acute hypercholesterolemia in rabbits: reversal with lovastatin treatment. J Clin Invest 1989; 83: 465-473
18. Benzuly KH, Padgett RC, Kaul S, Piegors DJ, Armstrong ML, Heistad DD Functional improvement precedes structural regression of atherosclerosis. Circulation 1994; 89: 1810-1818 [Erratum, Circulation 1994;90:1585.]
19. Leung W-H, Lau C-P, Wong C-K Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients. Lancet 1993; 341: 1496-1500.
20. Steinberg D Antioxidants and atherosclerosis: a current assessment. Circulation 1991; 84: 1420-1425.
21. Simon BC, Cunningham LD, Cohen RA Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75-79
22. Mangin EL Jr., Kugiyama K, Nguy JH, Kerns SA, Henry PD Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res 1993; 72: 161-166
23. Urien S, Riant P, Albengres E, Brioude R, Tillement JP In vitro studies on the distribution of probucol among human plasma lipoproteins. Mol Pharmacol 1984; 26: 322-327
24. Parthasarathy S, Young SG, Witztum JL, Pittman RC, Steinberg D Probucol inhibits oxidative modification of low density lipoprotein. J Clin Invest 1986; 77: 641-644
25. Simon BC, Haudenschild CC, Cohen RA Preservation of endothelium-dependent relaxation in atherosclerotic rabbit aorta by probucol. J Cardiovasc Pharmacol 1993; 21: 893-901
26. Ohara Y, Peterson TE, Harrison DG Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91: 2546-2551.
27. Graham A, Hogg N, Kalyanaraman B, O'Leary V, Darley-Usmar V, Moncada S Peroxynitrite modification of low-density lipoprotein leads to recognition by the macrophage scavenger receptor. FEBS Lett 1993; 330: 181-185
28. Plane F, Jacobs M, McManus D, Bruckdorfer KR Probucol and other antioxidants prevent the inhibition of endothelium-dependent relaxation by low density lipoproteins. Atherosclerosis 1993; 103: 73-79